Almasry Pharmacy

Goutifade 80 Mg 20 Tablets

Short Description:
Goutifade 80 mg 20 tablets is a febuxostat-based prescription medicine for long-term control of high uric acid in adults with gout. It helps reduce gout attacks, urate crystal deposition, and joint damage with convenient once-daily dosing under medical supervision.

EGP 48

Out of Stock
We'll message you as soon as it's back in stock.
delivery-iconDelivery to governorates within 3-4 working days
refund-iconEasy returns within 14 days
Specifications
SKUISG003265
BrandGoutifadeLink Icon
Categories
Medication & Treatments
Color
Luscious Blackberry
Concentrations
80 Mg
Shop by ConcernsGoutLink Icon, HyperuricemiaLink Icon, Joint PainLink Icon, TophiLink Icon
Gender
Neutral
Shop By GoalsGout ManagementLink Icon, Joint ProtectionLink Icon, Uric Acid ManagementLink Icon
Imported Or LocalLocal
Ingredient
Febuxostat
UPC
6223002142323
Product Form
Tablets
Specialty
Clinically Tested
Prescription only
Sub Categories
Gout Medicines
Unit Count
20 Tablets
Warning
Keep Out of Reach of Children
caution in heart conditions
kidney disease
liver
Not for acute conditions
Use under medical supervision only
About the product›

Goutifade 80 Mg 20 Tablets

Description:

Goutifade 80 mg 20 tablets is a prescription oral medicine containing febuxostat, a xanthine oxidase inhibitor used to lower high uric acid levels in the blood. It is indicated for the long-term management of chronic hyperuricaemia in patients with gout where urate crystal deposition has already occurred, helping to prevent gout flares, tophi formation, and joint damage. Manufactured by Global Napi Pharmaceuticals, Goutifade provides targeted uric acid control for adults requiring effective gout management under medical supervision.


Indications:

  • Treatment of chronic hyperuricaemia in adults with gout where urate deposition has already occurred (e.g., history or presence of gouty arthritis or tophi).
  • Reduction of serum uric acid levels in patients with recurrent gout attacks.
  • Prevention of complications associated with long-standing high uric acid levels, such as joint pain, swelling, stiffness, and deformity due to urate crystal deposition.
  • May be used as part of a long-term gout management plan including diet, lifestyle modification, and other medications as prescribed by a physician.

Active Ingredients / Key Components:

  • Febuxostat – 80 mg per film-coated tablet.
  • Excipients: Information on inactive ingredients (e.g., fillers, binders, colorants, preservatives) is not available in the provided data. Please refer to the official package leaflet for the full excipient list.

Dosage & Administration / How to Use:

  • Recommended dose for adults: 1 tablet of Goutifade 80 mg once daily, or as directed by your physician.
  • Can be taken with or without food; swallow the tablet whole with a glass of water, without crushing or chewing.
  • Use is intended for long-term treatment of hyperuricaemia in gout; do not stop the medication without consulting your doctor, even if symptoms improve.
  • Your doctor may adjust the dose based on your serum uric acid levels, response to treatment, and overall health status.
  • It is common for gout attacks to occur at the start of uric acid–lowering therapy; your doctor may prescribe additional medicines (e.g., NSAIDs or colchicine) to help prevent or manage flares during initiation.
  • If you miss a dose, take it as soon as you remember on the same day. If it is almost time for the next dose, skip the missed dose and resume your regular schedule. Do not double the dose to make up for a missed tablet.
  • Use only under medical supervision and follow your doctor’s instructions and the patient information leaflet carefully.

Clinical Benefits:

  • Effectively lowers elevated serum uric acid levels in patients with gout by inhibiting xanthine oxidase, the key enzyme in uric acid production.
  • Helps reduce the frequency and severity of gout attacks over time when used regularly as prescribed.
  • Supports prevention of urate crystal deposition in joints and tissues, helping to limit joint damage, deformity, and tophi formation.
  • Provides once-daily oral dosing, improving convenience and adherence to long-term gout management therapy.

Warnings & Contraindications:

  • Contraindicated in patients with known hypersensitivity to febuxostat or any component of the formulation.
  • Use with caution in patients with a history of major cardiovascular disease (e.g., heart attack, stroke, unstable angina); discuss risks and benefits with your doctor.
  • Use with caution in patients with severe kidney or liver impairment; dose adjustment or alternative therapy may be required.
  • Not recommended for the treatment of asymptomatic hyperuricaemia (elevated uric acid without gout symptoms) unless specifically advised by a physician.
  • Do not use to treat acute gout attacks; it is for long-term uric acid control. Acute flares should be managed with appropriate acute gout medications.
  • Inform your doctor about all medications you are taking, including azathioprine, mercaptopurine, theophylline, and other gout medicines, as interactions may occur.
  • Consult your doctor before use if pregnant, planning pregnancy, or breastfeeding. Safety data in pregnancy and lactation are limited.
  • Patients with a history of severe skin reactions (e.g., Stevens–Johnson syndrome) to febuxostat or similar drugs should not use this product.
  • Monitor liver function and serum uric acid periodically as recommended by your healthcare provider.
  • Consult your doctor before use if you have heart disease, stroke history, kidney disease, liver disease, thyroid disorders, or are taking other chronic medications.
  • Keep out of reach of children.

Side Effects:
  • Common side effects may include headache, nausea, diarrhea, joint pain, mild rash, or abnormal liver function tests.
  • Some patients may experience gout flares, especially at the beginning of treatment, as uric acid levels start to decrease.
  • Less common but serious side effects may include severe allergic reactions, serious skin reactions (such as Stevens–Johnson syndrome), liver problems, or cardiovascular events (e.g., chest pain, shortness of breath, sudden weakness).
  • Stop the medicine and seek immediate medical attention if you experience severe rash, blistering, peeling skin, swelling of the face or throat, difficulty breathing, chest pain, sudden weakness, or yellowing of the skin or eyes.
  • Report any persistent or bothersome side effects to your doctor or pharmacist.

Storage Instructions:

Store in a cool, dry place away from direct sunlight. Keep container tightly closed. Keep out of reach of children. Do not use after the expiry date shown on the pack. Store at or below the temperature specified on the outer packaging (refer to leaflet or box for exact storage temperature if needed).


Specifications:
  • Strength: 80 mg febuxostat per film-coated tablet.
  • Form: Oral film-coated tablets.
  • Pack size: 20 tablets per pack.
  • Intended use: Prescription medicine for adults for the long-term management of hyperuricaemia in gout.

Disclaimer:
All pharmacy products are intended for general use only and do not replace professional medical advice, diagnosis, or treatment. Always consult a healthcare provider before use. Results may vary, and no specific outcomes are guaranteed. Products are not intended to diagnose, treat, cure, or prevent any disease unless stated. Follow label instructions carefully, as misuse may cause adverse effects. Compliance with local laws is the customer’s responsibility.

More fromGoutifade

See More

Product Reviews

Overall Rating
Customer Reviews
No reviews yet
TelegramWhatsApp